Loading clinical trials...

Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT01417858

Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs

The purpose of this study is to compare the intra-ocular (IOP) control efficacy between brimonidine 0.1% vs. 0.2% after laser peripheral iridotomy (LPI).

Lead sponsor: Universidade Federal do Paraná•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Lucas Shiokawa, MD

CONTACT

55 41 91432398 lucasshiokawa@yahoo.com.br

Dayane Issaho, MD

CONTACT

day_issaho@yahoo.com.br

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment50

Start dateNov 2010

Last updatedAug 16, 2011

Condition

Glaucoma, Narrow Angle

Locations shown

Universidade Federal do Parana

Curitiba, Paraná

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 16, 2011Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions